𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Excellent Long-Term Survival in Patients With Primary Biliary Cirrhosis and Biochemical Response to Ursodeoxycholic Acid

✍ Scribed by Albert Parés; Llorenç Caballería; Juan Rodés


Book ID
119759032
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
120 KB
Volume
130
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Biochemical response to ursodeoxycholic
✍ Christophe Corpechot; Ludovico Abenavoli; Nabila Rabahi; Yves Chrétien; Tony And 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB 👁 1 views

Biochemical response to ursodeoxycholic acid (UDCA) in patients with primary biliary cirrhosis (PBC) is variable. It has been recently proposed that an alkaline phosphatase (ALP) decline of more than 40% in baseline value or a normal level after 1 year of UDCA treatment (Barcelona criteria) could se

Comment on biochemical response to ursod
✍ Lucy J. Walker; Julia Newton; David E. J. Jones; Margaret F. Bassendine 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

We read with interest the article by Corpechot et al. in a recent issue of HEPATOLOGY. 1 Corpechot et al. identify the absence of a biochemical response to ursodeoxycholic acid (UDCA) as an important predictive factor for death or liver transplantation in patients with primary biliary cirrhosis (PBC

Atorvastatin in patients with primary bi
✍ Tatjana Stojakovic; Csilla Putz-Bankuti; Günter Fauler; Hubert Scharnagl; Martin 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB 👁 1 views

Statin therapy may target both hypercholesterolemia and cholestasis in primary biliary cirrhosis (PBC). However, little is known about the efficacy and safety of statins in PBC. The aim of this single-center study was therefore to prospectively examine the effects of atorvastatin on serum markers of